HLB Science (XKRX:343090) Scaled Net Operating Assets : (As of . 20)

View and export this data going back to 2020. Start your Free Trial

What is HLB Science Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

HLB Science's operating assets for the quarter that ended in . 20 was ₩ Mil. HLB Science's operating liabilities for the quarter that ended in . 20 was ₩ Mil. HLB Science's Total Assets for the quarter that ended in . 20 was ₩ Mil. Therefore, HLB Science's scaled net operating assets (SNOA) for the quarter that ended in . 20 was .

HLB Science Scaled Net Operating Assets Historical Data

The historical data trend for HLB Science's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Scaled Net Operating Assets Chart

HLB Science Annual Data

Trend

Dec22

Dec23

Scaled Net Operating Assets

-0.40

-0.06

HLB Science Quarterly Data

Scaled Net Operating Assets

Competitive Comparison of HLB Science's Scaled Net Operating Assets

For the Biotechnology subindustry, HLB Science's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HLB Science's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Science's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where HLB Science's Scaled Net Operating Assets falls into.

HLB Science Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

HLB Science's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(903.765	-	1220.604)	/	5221.828
=	-0.06

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3950.314	-	3046.549
=	903.765

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2329.584	-	1004.794	-	104.186
=	1220.604

HLB Science's Scaled Net Operating Assets (SNOA) for the quarter that ended in . 20 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: . 20 )
=	(Operating Assets (Q: . 20 )	-	Operating Liabilities (Q: . 20 ))	/	Total Assets (Q: . 20 )
=	(	-	)	/
=

where

	Operating Assets		(Q: . 20 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=		-
=

	Operating Liabilities		(Q: . 20 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=		-		-
=

HLB Science Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of HLB Science's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Science (XKRX:343090) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR

Website

http://www.hlbscience.com

HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines